William Reeves plans FLD (FLD) Rule 144 sale after restricted stock vests

Rhea-AI Filing Summary

William Reeves filed to sell common stock of FLD under Rule 144. The planned sale relates to 5,082 shares of common stock that vested as restricted stock on July 31, 2026 as compensation from the issuer and are listed on NASDAQ.

The filing also lists prior open-market sales of common stock during May–July 2026, including 5,537 shares on May 4, 2026 for an aggregate value of 7,873.61 and 9,681 shares on May 18, 2026 for an aggregate value of 12,008.31.

Key Figures

Planned shares to be sold: 5,082 shares Sale on May 4, 2026: 5,537 shares; 7,873.61 aggregate value Sale on May 18, 2026: 9,681 shares; 12,008.31 aggregate value +2 more

5 metrics

Planned shares to be sold 5,082 shares Common stock from restricted stock vesting on July 31, 2026

Sale on May 4, 2026 5,537 shares; 7,873.61 aggregate value Common stock sold during the past three months

Sale on May 18, 2026 9,681 shares; 12,008.31 aggregate value Common stock sold during the past three months

Sale on May 19, 2026 10,681 shares; 13,001.98 aggregate value Common stock sold during the past three months

Sale on July 2, 2026 4,868 shares; 2,396.51 aggregate value Common stock sold during the past three months

Key Terms

Rule 144, Restricted Stock Vesting, aggregate value, compensation

4 terms

Rule 144 regulatory

"filed to sell common stock of FLD under Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 07/31/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

aggregate value financial

"5,537 shares on May 4, 2026 for an aggregate value of 7,873.61"

compensation financial

"07/31/2026 | Compensation"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 04:10 PM Accepted by SEC EDGAR 08/03/2026 - 04:10 PM Learn about SEC filing dates

FAQ

What does the FLD Form 144 filing by William Reeves disclose?

The filing shows William Reeves plans to sell common stock of FLD under Rule 144, tied to 5,082 restricted shares that vested on July 31, 2026 as compensation from the issuer.

How many FLD shares does William Reeves plan to sell under this Form 144?

The Form 144 covers a proposed sale of 5,082 shares of FLD common stock. These shares are associated with restricted stock vesting dated July 31, 2026 and categorized as compensation from the issuer.

What is the source of the FLD shares in William Reeves’ planned Rule 144 sale?

The planned sale involves FLD common shares received through Restricted Stock Vesting. The filing identifies the issuer as the source and classifies the 5,082 shares as compensation vesting on July 31, 2026.

What prior FLD stock sales by William Reeves are reported in the Form 144?

The document lists several FLD common stock sales in May–July 2026, including 5,537 shares on May 4, 2026 and 9,681 shares on May 18, 2026, each with corresponding aggregate value figures for those transactions.

On which market is the FLD common stock in this Form 144 listed?

The common stock referenced in the filing is listed on the NASDAQ market. The Form 144 identifies the security as FLD common stock traded on NASDAQ in connection with the planned Rule 144 sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5082	2386.51	50783350	08/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/31/2026	Restricted Stock Vesting	Issuer			5082	07/31/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
William Reeves 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	05/04/2026	5537	7873.61
William Reeves 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	05/18/2026	9681	12008.31
William Reeves 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	05/19/2026	10681	13001.98
William Reeves 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	05/21/2026	7713	9378.24
William Reeves 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	05/22/2026	8698	9967.91
William Reeves 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	05/26/2026	9221	9810.22
William Reeves 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	05/27/2026	8841	8711.92
William Reeves 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	05/28/2026	8113	8044.85
William Reeves 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	06/02/2026	5639	5104.42
William Reeves 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	07/02/2026	4868	2396.51

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)